Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Benzinga·05/04/2026 12:02:09
Listen to the news
U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Monday.
Shares of Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) fell in pre-market trading following first-quarter results.
Norwegian Cruise Line reported quarterly earnings of 23 cents per share which beat the analyst consensus estimate of 14 cents per share. The company reported quarterly sales of $2.331 billion which missed the analyst consensus estimate of $2.357 billion.
The company also cut its FY2026 adjusted EPS guidance from $2.38 to $1.45-$1.79.
Norwegian Cruise Line shares dipped 4.9% to $17.89 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
- Xanadu Quantum Technologies (NASDAQ:XNDU) shares dipped 66.9% to $11.97 in pre-market trading. Xanadu will report first quarter financial results on May 14.
- Tuniu Corp (NASDAQ:TOUR) fell 14.2% to $6.10 in pre-market trading.
- Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) shares tumbled 7.4% to $31.50 in pre-market trading after surging 89% on Friday. Hemab Therapeutics priced its upsized initial public offering of 16.75 million common shares at $18.00 per share.
- Nextdoor Holdings Inc (NYSE:NXDR) fell 7.3% to $1.53 in pre-market trading.
- Evolus Inc (NASDAQ:EOLS) fell 6.2% to $5.00 in pre-market trading. Evolus will report first quarter financial results on May 4.
- Valneva SE (NASDAQ:VALN) declined 6.2% to $5.02 in pre-market trading.
- Aura Biosciences Inc (NASDAQ:AURA) fell 5.8% to $6.60 in pre-market trading after the company announced a proposed public offering of common stock and pre-funded warrants. The company also named Natalie Holles as new CEO.
- Enovis Corp (NYSE:ENOV) declined 5.7% to $22.27 in pre-market trading.
- Spyre Therapeutics Inc (NASDAQ:SYRE) dipped 5.4% to $65.70 in pre-market trading. Spyre Therapeutics announced grants of inducement awards.
Photo via Shutterstock
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.